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Background/Aims: Recent in vivo studies using proton 
magnetic resonance (lH-MR) spectroscopy showed low 
levels of myoinositol in the brain in hepatic encepha- 
lopathy; the pathogenetic relevance of this observation 
is unclear. Methods: Myo-inositol and glutamine levels 
in the brain were studied in vivo by ‘H-MR spectroscopy 
in patients with hypo-osmolarity and hepatic encepha- 
lopathy. Results: A patient with severe plasma hype- 
osmolarity (222 mOsm/L) had almost undetectable 
signals for myoinositol and glutamine/glutamate in the 
brain. Both signals reappeared after normalization of 
plasma osmolarity, suggesting that both my@inositol 
and glutamine were released as organic osmolytes 
from the brain. A decreased cerebral myoinositol signal 
is also found in low-grade hepatic encephalopathy but 
is accompanied by an increased glutamine signal. Cir- 
rhotics without hepatic encephalopathy have near-nor- 
mal inositol signals, and patients with acquired immu- 
nodeficiency syndrome encephalopathy have increased 
inositol signals. Conc/u.sions:The ‘H-MR spectroscopic 
my&inositol signal in the human brain predominantly 
reflects an osmosensitive inositol pool. It is hypothe- 
sized that its depletion in latent hepatic encephalopa- 
thy points to a disturbance of cell volume homeostasis 
in the brain as an early pathogenetic event. This may 
partly be caused by a hyperammonemia-induced gluta- 
mine accumulation in the brain. 
T 
he pathogenesis of portosystemic hepatic encepha- 
lopathy (PSE) is still unclear, although a variety of 
mechanisms have been implicated, such as the action of 
ammonia and other neurotoxins, disturbances of the 
blood-brain barrier, and alterations of various neurotrans- 
mitter systems and their receptors (for review, see Lock- 
wood’ and Ferenci et al.“). In PSE, no morphological 
abnormalities of the neurons are detectable, but 
astrocytes show signs of Alzheimer type II degeneration. 
Such Alzheimer type II changes can be induced even in 
cultured astrocytes in vitro by addition of ammonia.’ In 
view of the increasing evidence for an important role of 
astrocytes in maintaining proper neuronal function, 4.5 it 
was hypothesized that PSE is a primary disorder of the 
astrocytes, with neuronal dysfunction being a secondary 
event.’ Astrocytes are the only cellular compartment in 
the brain capable of glutamine synthesis,’ which is the 
major pathway for cerebral ammonia detoxication. 
Whereas brain edema in hepatic encephalopathy of acute 
liver failure is common and eventually determines the 
patients’ final outcome, low-grade (I-III) PSE in chronic 
liver disease is generally not considered to involve cell 
swelling in the brain. Proton magnetic resonance (‘H- 
MR) specrroscopy can be used to study metabolic abnor- 
malities in the brain of patients with PSE in vivo. A 
marked decrease of myo-inositol signal and an increase of 
the glutamine signal were reported using this method.‘*’ 
Such alteration could also be induced in the rat after 
portocaval shunting.” However, the significance of these 
findings remained uncertain. 
Methods 
‘H-MR Spectroscopy and Patients 
Spectra were acquired on a 2-tesla whole-body system 
(Bruker S 200F; Bruker Medizintechnik, Rheinstetten, Ger- 
many) equipped with actively shielded gradients (10 millitesla 
[mTj/m, 1 -millisecond ramp time). Single-voxel spectroscopy 
using the point-resolved spectroscopy (PRESS) sequence”’ was 
used throughout. Voxels were located on coronal and transver- 
sal localizer images. An appropriate parietal location was cho- 
sen to represent signal from white matter primarily; for grey 
matter, a location in the occipital lobe was selected. Then 256 
averages were acquired from a 2.5 X 2.5 X 2.5-cm’ voxel. 
Spectra were read out with an echo time of 30 milliseconds 
and a repetition time of 1500 milliseconds. For postprocessing, 
Abbreviations used in this paper: AIDS, acquired immunodeficiency 
syndrome; HIV, human immunodeficiency virus; ‘H-MR, proton mag- 
netic resonance (spectroscopy); NCT, number connecting test; 
PRESS, point resolved spectroscopy; PSE, portosystemic hepatic en- 
cephalopathy; TIPS, transjugular intrahepatic portosystemic shunting. 
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Lorentzian line-broadening by 1 Hz was applied. Automated 
phase correction was applied using a volume-selective water 
signal acquired before the measurement as reference. For quan- 
tification of the spectroscopic changes, the ratio of myo-inositol 
to N-acetylaspartate in parietal spectra was used. The error in 
the individual ratio calculated from the noise of the spectra 
was 0.03-0.04. In seven healthy individuals, the myo-inositoli 
N-acetylaspartate ratio was found to be 0.39 t 0.03 (mean % 
SEM), which corresponds well with the literature value of 
0.42.” 
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Informed consent for the ‘H-MR spectroscopic examination 
was obtained from all patients. The grading of hepatic encepha- 
lopathy was performed by clinical examination (consciousness, 
flapping tremor, or personality changes) and psychometric tests 
(number connection test [NCT] and trail making test).’ Cir- 
rhotic patients who had no overt clinical symptoms of encepha- 
lopathy but who required a time period exceeding the normal 
range found in an age-matched control group’2,” to perform 
the NCT were considered to have latent hepatic encephalopa- 
thy. Normal values for the NCT were <37, <46, < 53, and 
<bO seconds for the age groups <29, 30-44, 45-60, and 
>61 years, respectively.‘2*‘i In all patients with hepatic en- 
cephalopathy in the study, liver cirrhosis was proven by histo- 
logical examination and was caused by chronic viral hepatitis. 
Acquired immunodeficiency syndrome (AIDS) encephalopathy 
was diagnosed from the diffuse leukoencephalopathy in nuclear 
MR images in patients with AIDS. Seven patients with hepatic 
encephalopathy and four patients with AIDS who had human 
immunodeficiency virus (HIV) encephalopathy were studied; 
representative ‘H-MR spectra are shown. 
Results 
A possible clue to the understanding of the MR 
spectroscopic myo-inositol signal in the human brain 
came from the ‘H-MR spectroscopic examination of a 
49-year-old woman with severe hypo-osmolarity (222 
2 
Figure 1. IH-MR spectra from a 49-year-old woman with severe hypo- 
osmolarity and after correction of hyponatremia. The first spectrum 
(October 10, 1993) was taken at a plasma osmolarity of 222 mOsm/ 
L and the others (October 14 and October 22, 1993) during recovery 
with plasma osmolarities of 280 and 195 mOsm/L, respectively. Pro- 
ton spectroscopy was performed using a single-voxel selective PRESS 
experimentlO with a 30-millisecond echo time. Water suppression was 
achieved by an optimized 90-90-180 presaturation scheme.38 Spectra 
were acquired at parietal and bioccipital locations with identical find- 
ings; parietal spectra are shown. Typical voxel size was 2.5 cm3; 
256 signals were averaged to increase the signal-to-noise of the final 
spectra. A ~-HZ exponential line-broadeningwas applied before Fourier 
transformation. All spectra were acquired on a 2-tesla whole-body 
system (Bruker S 200 F) using a standard head coil. Glx. glutamine/ 
glutamate; NAA, Nacetylaspartate; Ino, myoinositol; Cr, creatinine/ 
phosphocreatine; Cho, choline. 
mOsm/L) caused by autoimmune Addison’s disease (Fig- 
ure 1). The patient was otherwise healthy, except for 0.20 (examination on October 10) to 0.26 (examination 
asymptomatic cholecystolithiasis, and had adynamia and 
low serum sodium (10 1 mmol/L) and chloride levels (86 
mmol/L). The ‘H-MR spectrum (Figure 1) showed al- 
most undetectable signals for myo-inositol and glutamine/ 
glutamate. After standard treatment with glucocorticoids 
and mineralocorticoids, plasma osmolarity slowly nor- 
malized. Repeated ‘H-MR spectroscopic examinations 
showed the reappearance of the glutamine/glutamate sig- 
nal within 5 days (not shown) when plasma osmolarity 
was 280 mOsm/L, whereas the myo-inositol signal started 
to reappear after about 2 weeks (recording from October 
22 in Figure 1) when a normal plasma osmolarity of 295 
mOsm/L was reached; the signal was fully recovered after 
7-8 weeks (Figure 1, recording from March 12). The 
ratio of myo-inositol to N-acetylaspartate increased from 
on October 22) to a nearly normal level of 0.32 (examina- 
tion on March 12). Despite the marked abnormalities in 
the ‘H-MR spectrum, only minor neurological abnor- 
malities were detectable on admission (hyporeflexia, dis- 
crete psychomotoric slowness). Also, the time required 
to perform the NCT (3 1 seconds on October 10 and 25 
seconds on November 29) was within the range of the 
age-matched controls. A marked loss of myo-inositol was 
also observed in a 71-year-old woman with hypo-osmo- 
larity (243 mOsm/L); only short-term follow-up of this 
multimorbid patient was possible, but when plasma os- 
molarity increased to 286 mOsm/L, a partial reappear- 
ance of the myo-inositol signal was observed. 
For comparison, ‘H-MR spectra from a healthy control 
individual and cirrhotic patients with latent and grade I- 
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II PSE are shown in Figure 2A-C. In line with previous 
reports of latent and manifest PSE,‘.*.‘” a significant de- 
crease of the myo-inositol signal and an increased intensity 
of the glutamineiglutamate signal was consistently found 
in all seven patients with liver cirrhosis (of viral and 
alcoholic origin). On the other hand, near-normal cere- 
bral inositol signals were found in a 4%year-old woman 
,“..1.“‘I”“@ “’ 
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Figure 2. Parietal ‘H-MR spectra from (A) a healthy person; patients 
with (13) posthepatitic cirrhosis and latent PSE or (C) manifest grade 
I-II PSE: and (D) an AIDS patient with HIV encephalopathy. For experi- 
mental details, see Figure 1. Patients with HIV encephalopathy had 
diffuse leukoencephalopathy as detected by nuclear MR imaging, re 
fleeting the gliosis known to be associated with the disorder.26 Repre- 
sentative spectra are given. The massive increase in the myoinositol 
signal in HIV leukoencephalopathy was consistently found in all four 
patients studied up to now. Likewise, the decrease of the myoinositol 
signal and the increase in glutamine signal was a consistent finding 
in all patients studied with hepatic encephalopathy. in line with other 
reports.8.*4 All patients (A-D) were women and were 40, 71,60. and 
31 years old, respectively; in those with PSE, the cirrhosis was of 
viral origin. 
with cryptogenic liver cirrhosis without evidence for la- 
tent (NCT, 39 seconds) or manifest hepatic encephalopa- 
thy (data not shown). This suggests that a marked loss 
of cerebral myo-inositol levels, as detected by ‘H-MR 
spectroscopy, is not a feature accompanying cirrhosis in 
general but is apparently related to the presence of he- 
patic encephalopathy. A high sensitivity and specificity 
of the myo-inositol signal for the diagnosis of hepatic 
encephalopathy in cirrhotics has been reported. I4 
In the rat, portocaval shunting results in a lowering 
of brain myo-inositol levels.” In line with this were the 
spectroscopic findings on a 46-year-old patient with alco- 
holic cirrhosis who underwent transjugular intrahepatic 
portosystemic shunting (TIPS). As shown in Figure 3, a 
normal spectrum was obtained 3 days before TIPS, 
whereas the spectrum recorded 1 week after the TIPS 
procedure showed an increased glutamineiglutamate sig- 
nal and a slight lowering of the myo-inositol signal. The 
myo-inositollN-acetylasparrate signal ratio decreased from 
0.33 (3 days before TIPS) to 0.28 1 week after the TIPS 
procedure. No overt signs of hepatic encephalopathy, 
except some fatigue, developed. However, the time pe- 
riod required for performance of the NCT was normal 
(38 and 42 seconds before and after TIPS, respectively). 
On the other hand, a 69-year-old cirrhotic patient devel- 
oped grade III hepatic encephalopathy after the TIPS 
procedure and showed a markedly reduced myo-inositol 
I 
In0 Cr 
3 days before TIPS 
7 days after TIPS 
3 1 ppm 
Plgure 3. Parietal ‘H-MR spectra from a 47.year-old patient with alto 
holic cirrhosis 3 days before and 7 days aher implantation of TIPS 
showing some reduction of myoinositol signal after the intervention. 
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signal in the brain. Reocclusion of the TIPS was followed 
by a rapid and complete resolution of the encephalopathic 
symptoms (NCT, 45 seconds) and was accompanied by 
a partial recovery of the myo-inositol signal (not shown). 
In contrast to the findings in hepatic encephalopathy, 
the myo-inositol signal was found to be strongly increased 
in four patients with AIDS who had HIV encephalopathy 
and gliosis (Figure 20), as evidenced by the diffuse leu- 
koencephalopathy found in nuclear MR images (not 
shown). This suggests that a loss of myo-inositol is not a 
general feature of all types of encephalopathy. 
Discussion 
Myo-inositol As an Osmolyte in Human 
Brain 
In general, cell swelling occurs when cells are 
either exposed to hypo-osmotic environments or when 
they accumulate osmotically active solutes (for review, 
see Haussinger and Lang15). The latter occurs under the 
influence of hormones, cumulative substrate uptake into 
the cell, or enhanced intracellular synthesis of poorly 
permeant metabolites. Whereas minor alterations of cel- 
lular hydration (i.e., cell volume changes below 10%) 
were recently recognized to act as a physiological signal, 
which triggers cell function,‘5v’” excessive cell swelling is 
apparently harmful and activates counteracting volume- 
regulatory mechanisms.15 In all cell types, such volume- 
regulatory mechanisms involve ion fluxes, but in some, 
such as renal medulla cells and glia cells, cell volume 
regulation is in addition accomplished by use of organic 
osmolytes, i.e., compounds that are specifically accumu- 
lated inside or released from the cells in response to cell 
shrinkage or swelling, respectively. Myo-inositol has been 
identified as a major osmolyte in renal medulla epithelia 
and astrocytes.43’7-‘9 Uptake and release of myo-inositol 
by these cells as well as the expression of genes coding 
for myo-inositol transporters in the plasma mem- 
brane ‘x~20z’ is regulated by osmolarity. That such osmo- 
lyte mechanisms may also operate in vivo is suggested 
by recent animal experiments, which showed a decrease 
of the myo-inositol content in the brains removed from 
rats undergoing experimental short-term hypona- 
tremia.” Myo-inositol release from brain cells in response 
to hypo-osmotic cell swelling may explain the loss of 
this osmolyte from the brain of the patient with severe 
hypo-osmolarity as well as the recovery of the signal 
after normalization of plasma osmolarity (Figure 1). The 
observation that also the glutamine/glutamate signal dis- 
appeared may indicate that these amino acids likewise 
acted as osmolytes. The role of myo-inositol as an osmolyte 
in human brain is further suggested by the observation 
that hypernatremia, which is expected to lead to cell 
shrinkage and to favor osmolyte accumulation in brain 
cells, is indeed associated with an increased myo-inositol 
signal as detected by ‘H-MR spectroscopy.” Thus, the 
findings strongly suggest that the myo-inositol signal 
picked up by ‘H-MR spectroscopy in human brain re- 
flects an osmosensitive myo-inositol pool, which is not 
associated with membrane phospholipids. Our study can- 
not answer the question which cell types in brain contain 
this osmosensitive myo-inositol pool. However, in vitro 
studies have shown that astrocytes contain high amounts 
of myo-inositol in contrast to neurons.23 In line with this, 
the myo-inositol signal is markedly enhanced in Alzhei- 
mer’s disease” and HIV encephalopathy (Figure 20), 
i.e., disorders known to be associated with neuronal atro- 
phy and gliosis, astrocyte proliferation, and hyperpla- 
sia. 26.27 
Brain mydnositol in hepatic encephalopathy. 
The observations on the patients undergoing TIPS as 
well as morphological studies in hepatic encephalopa- 
thyIs may argue against the possibility that the loss of 
myo-inositol in PSE is caused by a marked reduction of 
the number of brain cells containing this sugar. In view 
of the data shown in Figure 1, a more likely explanation 
is that the markedly decreased myo-inositol signals in 
patients with PSE (Figure 28 and C) reflect a disturbance 
of cell volume homeostasis in brain, which may occur 
already at preclinical stages of PSE in vivo. This distur- 
bance of brain cell volume homeostasis in PSE may at 
least in part be attributed to an intracellular accumula- 
tion of glutamine in response to hyperammonemia. The 
‘H-MR signal for glutamine is increased with a compen- 
satory loss of myo-inositol content in both latent and 
manifest PSE, with the alterations being less pronounced 
in the latent stage (Figure 28 and C and Figure 3). If 
this interpretation of a volume-regulatory myo-inositol 
release in response to ammonia-induced glutamine accu- 
mulation in the brain is correct, and considering the fact 
that glutamine formation from ammonia is a glial but not 
a neuronal process,” glial cell swelling could be involved. 
Indeed, cultured astrocytes swell under the influence of 
amm0nia.l” Because no significant neuropsychiatric ab- 
normalities were observed in the patient with severe 
plasma hypo-osmolarity (Figure 1) in contrast to the 
patients with PSE (Figure 2B and C), it seems that a 
“deficiency” of cerebral myo-inositol per se does not pre- 
dict major encephalopathy symptoms. However, the myo- 
inositol loss, which likely indicates glial swelling, may, 
when persistent, lead to sustained disturbances of cell 
function, with yet unknown consequences for glial-neu- 
ronal communication.5 As a matter of fact, in other 
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cell types (e.g., hepatocytes), cell swelling, even when 
<lo%, leads to marked alterations of carbohydrate 
and protein metabolism,‘5~‘“~29~~’ gene expression,“.” 
transport processes,‘s~‘6V30~‘3 protein phosphorylation and 
intracellular signaling,‘“~” and cytoskeletal organiza- 
tion. ‘533”‘32 It is not yet clear whether such findings can 
be extrapolated to brain cells; however, recent in vitro 
studies suggest that swelling of astrocytes affects trans- 
membrane ion fluxes,‘” acidification of intracellular vesic- 
ular compartments,33 protein phosphorylation,34 and 
other intracellular signaling pathways.“.35 Thus, the hy- 
pothesized cell swelling in PSE, as indicated by inositol 
release, could have important functional consequences 
despite the absence of clinically overt increases of intra- 
cranial pressure. Indeed, effects of cell swelling could 
explain several established phenomena in PSE, such as 
disturbances of cerebral glucose metabolism and alter- 
ations of blood-brain barrier permeability and glial cy- 
toskeletal proteins. Because astrocyte volume changes 
may not only be triggered by ammonia but also by hor- 
mones, excitatory amino acids,” peripheral type benzodi- 
azepines, 36 and mediators of inflammation, “).37 the hy_ 
pothesized role of glial swelling in the pathogenesis of 
PSE would also explain why many investigators have 
failed to show a correlation between plasma ammonia 
levels and the severity of PSE. 
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